v3.26.1
Fair value of financial instruments (Tables)
6 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments
The fair value and carrying value of our material fixed-rate debt, excluding any unamortized debt issuance costs, are as follows:
(In millions) June 30, 2026December 31, 2025

2027 Senior Unsecured Notes
Carrying value$600.0 600.0 
Fair value579.1 579.0 
2029 Senior Unsecured Notes
Carrying value$400.0 400.0 
Fair value406.3 412.2 
2032 Senior Unsecured Notes
Carrying value$400.0 400.0 
Fair value406.3 416.0 
Derivatives Not Designated as Hedging Instruments
The fair value of these contracts were recognized in the condensed consolidated balance sheet as follows:
(In millions) June 30, 2026December 31, 2025

Prepaid expenses and other
$7.9 4.2 
Accrued liabilities
(3.0)(5.3)
Net asset (liability) $4.9 (1.1)

Amounts under these contracts were recognized in other operating income (expense) as follows:
Three Months
Ended June 30,
Six Months
Ended June 30,
(in millions)2026202520262025
Derivative instrument gains (losses) included in other operating income (expense)(a)
$5.7 (22.6)$16.1 (35.2)
(a)Derivative instrument gains in the three months and six months ended June 30, 2026, were primarily driven by the impact of hedging currency exposures on intercompany loans denominated in the euro, the British pound, and the Mexican peso. Derivative instrument losses in the three month and six month ended June 30, 2025, were primarily driven by the impact of hedging currency exposures on intercompany loans denominated in the euro and the British pound.
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The fair value of these contracts were recognized in the condensed consolidated balance sheet as follows:
(In millions) June 30, 2026December 31, 2025

Euro net investment hedge(a)
Prepaid expenses and other
$2.1 2.1 
Accrued liabilities
(29.2)(34.2)
Other noncurrent liabilities
(25.8)(28.3)
Zero cost collar
Prepaid expenses and other$— 0.2 
Other currency net investment hedges(b)
Prepaid expenses and other
$1.7 0.5 
Other noncurrent asset0.3 0.2 
Accrued liabilities— (0.7)
Other noncurrent liabilities(3.9)(1.1)
Net asset (liability)$(54.8)(61.3)
(a)At June 30, 2026, swaps with a total notional value of $215 million will terminate in April 2027 and have a weighted average maturity of 0.8 years. Swaps with a total notional value of $185 million will terminate in April 2031 and have a weighted average maturity of 4.3 years.
(b)At June 30, 2026, the total notional value was $145 million with a weighted average maturity of 1.0 years. These contracts hedge portions of our net investments in subsidiaries with functional currencies of Hong Kong dollar; Singapore dollar; Japanese yen; Israeli shekel; Swiss franc; and Canadian dollar.
The fair values of our interest rate swaps were recognized in the condensed consolidated balance sheet as follows:
(In millions)June 30, 2026December 31, 2025

$100 million notional - June 2027 maturity (a)
Prepaid expenses and other$0.2 — 
Accrued liabilities
— (0.3)
Other noncurrent liabilities
— (0.3)
$50 million notional - June 2027 maturity (a)
Prepaid expenses and other$0.2 — 
Accrued liabilities— (0.1)
Other noncurrent liabilities
— (0.1)
Net asset (liability)$0.4 (0.8)
(a)At June 30, 2026, swaps with a total notional value of $150 million will terminate in June 2027 and have a weighted average maturity of 0.5 years.
Schedule of Interest Rate Derivatives
The effect of the amortization of the spot-forward difference on the net investment hedges cross currency swaps and foreign exchange forward swap contract is included as a benefit in interest expense as follows:
Three Months
Ended June 30,
Six Months
Ended June 30,
(In millions)2026202520262025
Cross currency swaps designated as net investment hedges
$(1.3)(1.2)$(2.8)(2.4)
Amounts under our interest rate swap contracts were recognized in interest expense as follows:
Three Months
Ended June 30,
Six Months
Ended June 30,
(In millions)2026202520262025

Impact to interest expense - (benefit) cost
$(1.0)(2.1)$(2.1)(4.6)